NathanielBErdmannMD

Infectious Disease • Birmingham, AL

Physician

Join to view full profile

Are you Dr. Erdmann?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 22 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
1717 6th Ave S
Birmingham, AL 35233
Phone+1 800-822-8816

Summary

Dr. Nathaniel Erdmann, MD is an infectious disease specialist in Birmingham, Alabama. He is currently licensed to practice medicine in Alabama. He is affiliated with University of Alabama Hospital.

Education & Training

University of Alabama Medical CenterFellowship, Infectious Disease, 2013 - 2015
University of Alabama Medical CenterResidency, Internal Medicine, 2010 - 2012
University of Nebraska College of MedicineClass of 2010

Certifications & Licensure

AL State Medical License 2012 - 2024

Publications & Presentations

PubMed

1 citations
HLA-II-Associated HIV-1 Adaptation Decreases CD4T-Cell Responses in HIV-1 Vaccine Recipients.
Jacob K Files, Sarah Sterrett, Sebastian Henostroza, Christopher Fucile, Kevin Maroney
Journal of Virology. 2022-09-14
48 citations
SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence.
Sushma Boppana, Kai Qin, Jacob K Files, Ronnie M. Russell, Regina Stoltz
Plos Pathogens. 2021-07-16
57 citations
Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries.
A Rouf Banday, Megan L Stanifer, Oscar Florez-Vargas, Olusegun O Onabajo, Brenen W Papenberg
Nature Genetics. 2022-08-01

Press Mentions

COVID-19: Bacterial Co-Infection Is a Major Risk Factor for Death, ICU Admission and Mechanical VentilationFebruary 28th, 2023
What We Know About Long COVID and How Long Symptoms LastAugust 25th, 2022
Demonstration of a Potent, Universal Coronavirus Monoclonal Antibody Therapy for All COVID-19 VariantsJuly 22nd, 2022
Join now to see all